Guillermo Espinosa-Ramírez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guillermo Espinosa-Ramírez has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Benjamín Pineda
Neuroimmunology Laboratory, National Institute of Neurology and Neurosurgery “Manuel Velasco Suárez”, Mexico City 14269, Mexico
2 shared publications Graciela Ordoñez
Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
2 shared publicationsJulio Sotelo
Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
2 shared publicationsAleli Salazar
Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
1 shared publication- Ana Campos Hernández
Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
1 shared publication Andrea Muñoz-Gómez
The ‡‡División de Medicina Interna, Departamento de Reumatología, Hospital Civil “Dr. Juan I. Menchaca,” Guadalajara, Jalisco CP 44340, México
1 shared publication
Latest Publications
- 8 July 2023
- Published by Elsevier in Archives of Medical Research
- Vol. 54 (5) , 102843
Conversion Predictors of Clinically Isolated Syndrome to Multiple Sclerosis in Mexican Patients: A Prospective Study
- 8 July 2023
- Published by Elsevier in Archives of Medical Research
- Vol. 54 (5) , 102843
Conversion Predictors of Clinically Isolated Syndrome to Multiple Sclerosis in Mexican Patients: A Prospective Study
- 12 January 2014
- Published by Taylor & Francis in Neurological Research
- Vol. 36 (7) , 647-650
Sunlight exposure and multiple sclerosis in a tropical country
We analysed past and current sun exposure in multiple sclerosis (MS) patients as compared with matched controls in Mexico, a country with tropical climate.
- 12 January 2014
- Published by Taylor & Francis in Neurological Research
- Vol. 36 (7) , 647-650
Sunlight exposure and multiple sclerosis in a tropical country
We analysed past and current sun exposure in multiple sclerosis (MS) patients as compared with matched controls in Mexico, a country with tropical climate.
- Open Access
- 24 September 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-15
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system. The hallmark to MS is the demyelinated plaque, which consists of a well-demarcated hypocellular area characterized by the loss of myelin, the formation of astrocytic scars, and the mononuclear cell infiltrates concentrated in perivascular spaces composed of T cells, B lymphocytes, plasma cells, and macrophages. Activation of resident cells initiates an inflammatory cascade, leading to tissue destruction, demyelination, and neurological deficit. The immunological phenomena that lead to the activation of autoreactive T cells to myelin sheath components are the result of multiple and complex interactions between environment and genetic background conferring individual susceptibility. Within the CNS, an increase of TLR expression during MS is observed, even in the absence of any apparent microbial involvement. In the present review, we focus on the role of the innate immune system, the first line of defense of the organism, as promoter and mediator of cross reactions that generate molecular mimicry triggering the inflammatory response through an adaptive cytotoxic response in MS.
- 24 September 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-15
Open AccessInitial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system. The hallmark to MS is the demyelinated plaque, which consists of a well-demarcated hypocellular area characterized by the loss of myelin, the formation of astrocytic scars, and the mononuclear cell infiltrates concentrated in perivascular spaces composed of T cells, B lymphocytes, plasma cells, and macrophages. Activation of resident cells initiates an inflammatory cascade, leading to tissue destruction, demyelination, and neurological deficit. The immunological phenomena that lead to the activation of autoreactive T cells to myelin sheath components are the result of multiple and complex interactions between environment and genetic background conferring individual susceptibility. Within the CNS, an increase of TLR expression during MS is observed, even in the absence of any apparent microbial involvement. In the present review, we focus on the role of the innate immune system, the first line of defense of the organism, as promoter and mediator of cross reactions that generate molecular mimicry triggering the inflammatory response through an adaptive cytotoxic response in MS.
- Open Access
- 1 October 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (43) , 32824-32833
Inhibitors of MAPK Pathway ERK1/2 or p38 Prevent the IL-1β-induced Up-regulation of SRP72 Autoantigen in Jurkat Cells
- 1 October 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (43) , 32824-32833
Open AccessInhibitors of MAPK Pathway ERK1/2 or p38 Prevent the IL-1β-induced Up-regulation of SRP72 Autoantigen in Jurkat Cells